Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer.

Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med. 2018 03 05; 215(3):895-910.

View in: PubMed

subject areas

Animals
Apoptosis
Bcl-2-Like Protein 11
Breast Neoplasms
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Proliferation
Cyclin D1
Cytokines
Down-Regulation
Drug Resistance, Neoplasm
Female
Fibroblast Growth Factor 2
Humans
Ligands
Mechanistic Target of Rapamycin Complex 1
Mice
Models, Biological
Molecular Targeted Therapy
Neoplasm Recurrence, Local
Phosphatidylinositol 3-Kinases
Receptors, Estrogen
Receptors, Fibroblast Growth Factor
Signal Transduction
Transcriptome
Treatment Outcome
Tumor Microenvironment
Up-Regulation

authors with profiles

CHAO CHENG